Rimal H Dossani Selected Research

Neurologic Manifestations (Neurological Manifestations)

1/2020

Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rimal H Dossani Research Topics

Disease

10	Stroke (Strokes) 12/2022 - 01/2020
6	Aneurysm (Aneurysms) 04/2022 - 01/2018
3	Cerebral Infarction 12/2022 - 01/2020
2	Ischemic Stroke 12/2022 - 08/2021
2	Meningioma (Meningiomas) 01/2022 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2021 - 01/2021
2	Rupture 01/2021 - 10/2020
2	Subdural Hematoma (Subdural Hemorrhage) 12/2020 - 01/2015
2	Neoplasms (Cancer) 10/2019 - 01/2018
1	Posterior Cerebral Artery Infarction (Posterior Cerebral Artery Syndrome) 02/2023
1	Pain (Aches) 02/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022
1	Atrophy 04/2022
1	Ruptured Aneurysm 04/2022
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 04/2021
1	Thrombosis (Thrombus) 02/2021
1	Subclavian Steal Syndrome (Subclavian Steal) 01/2021
1	Chronic Subdural Hematoma 12/2020
1	Intracranial Aneurysm (Cerebral Aneurysm) 10/2020
1	Moyamoya Disease (Moya-Moya Disease) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2019
1	Central Nervous System Cysts (Suprasellar Cyst) 02/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2018
1	Arachnoid Cysts (Intracranial Arachnoid Cysts) 01/2018
1	Cysts 01/2018
1	Familial spinal arachnoiditis 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Crohn Disease (Crohn's Disease) 01/2018
1	Relapsing-Remitting Multiple Sclerosis 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2017
1	Venous Thromboembolism 12/2017
1	Wounds and Injuries (Trauma) 12/2017
1	Congenital Abnormalities (Deformity) 11/2017
1	Parietal Foramina 11/2017
1	Hypertelorism 11/2017
1	Cauda Equina Syndrome 10/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2015
1	Hematologic Diseases (Blood Diseases) 01/2015
1	Bites and Stings (Sting) 01/2015
1	Hematoma 01/2015
1	Hemorrhage 01/2015

Drug/Important Bio-Agent (IBA)

2	mesoglycanIBA 04/2022 - 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2022
1	Indicators and Reagents (Reagents)IBA 04/2022
1	Adenosine (Adenocard)FDA LinkGeneric 04/2021
1	OF 743IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2019
1	Natalizumab (Tysabri)FDA Link 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	IntegrinsIBA 01/2018
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2015
1	A 7 (A-7)IBA 01/2015

Therapy/Procedure

13	Thrombectomy 02/2023 - 01/2020
8	Catheters 12/2022 - 12/2020
7	Stents 12/2022 - 10/2020
6	Therapeutics 04/2022 - 01/2018
4	Craniotomy 01/2022 - 11/2017
2	Punctures 12/2022 - 06/2022
2	Length of Stay 12/2022 - 12/2017
1	Early Ambulation 02/2023
1	Retreatment 04/2022
1	Off-Label Use 09/2020
1	Cerebral Revascularization 01/2020
1	Laminectomy 01/2018
1	Decompression 01/2018
1	Sutures (Suture) 11/2017
1	Osteotomy 11/2017
1	Surgical Decompression 10/2017
1	Conservative Treatment 01/2015